GO:0006513 protein monoubiquitination: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006513 protein monoubiquitination is the addition of a single ubiquitin group to a protein, a reversible post-translational modification distinct from polyubiquitination.
• Monoubiquitination acts as a signaling event that alters protein-protein interactions, localization, and activity rather than primarily targeting proteins for degradation.
• Key substrates include PCNA (regulated by RPA), FANCD2/FANCI, and ribosomal proteins, linking monoubiquitination to DNA replication, DNA repair, and ribosome quality control.
• Monoubiquitination can prime ubiquitin chain elongation, serving as an intermediate for polyubiquitin assembly.
• Dysregulation of monoubiquitination is implicated in cancer, Fanconi anemia, and ribosomopathies, making it a target for therapeutic and diagnostic research.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable functional dissection of monoubiquitination pathways in disease contexts.
Description
Protein monoubiquitination (GO:0006513) is a fundamental post-translational modification in which a single ubiquitin moiety is covalently attached to a target protein. Unlike polyubiquitination, which typically signals proteasomal degradation, monoubiquitination often functions as a non-degradative signal that modulates protein-protein interactions, subcellular localization, and enzymatic activity. This modification is dynamically regulated by E3 ubiquitin ligases and deubiquitinating enzymes, and it plays critical roles in diverse biological processes including DNA replication, DNA damage repair, endocytosis, and ribosome quality control. Researchers study protein monoubiquitination to understand how cells interpret ubiquitin signals and how disruption of these signals contributes to human disease. The modification generates structural diversity that allows a single ubiquitin tag to control distinct biological outcomes depending on the substrate and cellular context. For example, monoubiquitination of proliferating cell nuclear antigen (PCNA) is essential for translesion synthesis during DNA damage, while monoubiquitination of FANCD2 and FANCI is a hallmark of Fanconi anemia pathway activation. Recent advances have revealed that monoubiquitination can also serve as a priming event for ubiquitin chain elongation, expanding its regulatory repertoire beyond simple on/off switches. Understanding the enzymes, substrates, and downstream effectors of monoubiquitination is therefore central to both basic cell biology and translational research in cancer, neurodegeneration, and genetic disorders.
protein monoubiquitination At A Glance
| GO ID | GO:0006513 |
|---|---|
| GO term | protein monoubiquitination |
| Ontology | biological_process |
| Synonym | protein monoubiquitinylation, protein monoubiquitylation |
| Major function | Addition of a single ubiquitin group to a protein, often acting as a non-degradative signaling modification |
| Contrast with | Polyubiquitination, which involves ubiquitin chain formation and often targets proteins for degradation |
| Key enzymes | E1 activating enzymes, E2 conjugating enzymes, E3 ubiquitin ligases, and deubiquitinating enzymes |
| Representative substrates | PCNA, FANCD2, FANCI, ribosomal proteins, and many signaling receptors |
| Biological contexts | DNA replication, DNA repair, endocytosis, ribosome quality control, and immune signaling |
What Is GO:0006513?
According to the Gene Ontology, GO:0006513 protein monoubiquitination is defined as the addition of a single ubiquitin group to a protein. This process is also known as protein monoubiquitinylation or protein monoubiquitylation. It is a biological process that specifically involves the attachment of one ubiquitin molecule, in contrast to polyubiquitination where multiple ubiquitin moieties form a chain.
Why Is protein monoubiquitination Important in Cell Biology?
Protein monoubiquitination is critically important because it serves as a versatile regulatory switch that controls protein function without necessarily causing degradation. This modification allows cells to rapidly and reversibly alter protein interactions, localization, and activity in response to environmental cues, making it essential for processes such as DNA damage tolerance, Fanconi anemia pathway activation, and ribosome quality control. Dysregulation of monoubiquitination contributes to cancer, genetic instability, and developmental disorders, and the enzymes that catalyze or reverse this modification are emerging as therapeutic targets.
• Regulates DNA replication and translesion synthesis through PCNA monoubiquitination.
• Activates the Fanconi anemia DNA repair pathway via FANCD2 and FANCI monoubiquitination.
• Controls ribosome quality control and stalled ribosome dissociation through RNF10-mediated monoubiquitination.
• Serves as a priming step for ubiquitin chain elongation, linking monoubiquitination to polyubiquitin signaling.
• Modulates endocytosis and receptor trafficking by tagging cargo proteins for internalization.
• Alters protein-protein interaction networks, affecting complex assembly and signaling.
• Implicated in cancer development when E3 ligases or deubiquitinating enzymes are mutated.
• Provides structural diversity that allows distinct biological outcomes from a single ubiquitin tag.
• Offers potential biomarkers for Fanconi anemia and ribosomopathies.
• Enables therapeutic targeting of ubiquitin ligases and deubiquitinases in precision medicine.
What Happens During protein monoubiquitination?
Activation and Conjugation of Ubiquitin
In simple terms: Ubiquitin is first activated and then transferred to a target protein.
Monoubiquitination begins with the ATP-dependent activation of ubiquitin by an E1 activating enzyme, followed by transfer to an E2 conjugating enzyme. An E3 ubiquitin ligase then catalyzes the covalent attachment of a single ubiquitin moiety to a lysine residue on the substrate protein. This enzymatic cascade ensures substrate specificity and temporal control of the modification.
Substrate Recognition and Specificity
In simple terms: The E3 ligase chooses which protein gets the ubiquitin tag.
E3 ubiquitin ligases recognize specific degrons or structural features on target proteins, determining which substrates undergo monoubiquitination. For example, replication protein A (RPA) dynamically regulates monoubiquitination of proliferating cell nuclear antigen (PCNA) by controlling access of the E3 ligase RAD18. Similarly, the Fanconi anemia core complex coordinates monoubiquitination of FANCD2 and FANCI in response to DNA damage.
Functional Consequences of Monoubiquitination
In simple terms: The ubiquitin tag changes how the protein behaves.
Monoubiquitination can alter protein-protein interactions, subcellular localization, and enzymatic activity. It often serves as a non-degradative signal that recruits downstream effectors containing ubiquitin-binding domains. For instance, monoubiquitinated PCNA recruits translesion synthesis polymerases to sites of DNA damage, while monoubiquitinated FANCD2 and FANCI coordinate DNA repair.
Priming for Ubiquitin Chain Elongation
In simple terms: Monoubiquitination can be the first step toward building a ubiquitin chain.
Recent studies have shown that monoubiquitination can serve as a priming event for subsequent ubiquitin chain elongation. The E3 ligase RNF10 promotes dissociation of stalled ribosomes and responds to ribosomal subunit imbalance, and monoubiquitination can empower chain elongation by providing a substrate for further ubiquitin conjugation. This mechanism links monoubiquitination to polyubiquitin-dependent processes such as proteasomal degradation.
Reversal by Deubiquitinating Enzymes
In simple terms: The ubiquitin tag can be removed to reverse the signal.
Deubiquitinating enzymes (DUBs) can remove the single ubiquitin moiety from monoubiquitinated proteins, making the modification reversible and dynamically regulated. This reversibility allows cells to fine-tune signaling outcomes and recover from transient stresses.
Key Genes Involved in GO:0006513 protein monoubiquitination
The following genes and proteins are central to protein monoubiquitination, encompassing E3 ligases, substrates, and regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAD18 | E3 ubiquitin ligase that monoubiquitinates PCNA | Studied for translesion synthesis and DNA damage tolerance |
| PCNA | Substrate of monoubiquitination at Lys164 | Key marker of DNA replication stress and damage response |
| RPA | Regulates PCNA monoubiquitination by controlling RAD18 access | Investigated for replication fork protection |
| FANCD2 | Monoubiquitinated substrate in Fanconi anemia pathway | Diagnostic marker for Fanconi anemia and cancer predisposition |
| FANCI | Monoubiquitinated partner of FANCD2 | Studied for DNA interstrand crosslink repair |
| RNF10 | E3 ligase promoting ribosome dissociation and monoubiquitination | Linked to ribosome quality control and ribosomopathies |
| UBE2D1 | E2 conjugating enzyme for monoubiquitination | Model for E2 specificity studies |
| UBE2N | E2 enzyme involved in ubiquitin chain elongation | Studied in monoubiquitination priming |
| BRCA1 | E3 ligase with roles in DNA repair and monoubiquitination | Cancer research and Fanconi anemia cross-talk |
| BARD1 | Partner of BRCA1 in E3 ligase complexes | Investigated for breast and ovarian cancer |
| USP1 | Deubiquitinating enzyme for FANCD2 and PCNA | Target for cancer therapy |
| OTUB1 | Deubiquitinating enzyme regulating monoubiquitination | Studied in DNA damage response |
| UBQLN1 | Ubiquitin-binding protein affecting monoubiquitination | Linked to neurodegeneration |
| EPS15 | Monoubiquitinated substrate in endocytosis | Model for receptor trafficking |
| HGS | E3 ligase for monoubiquitination in endosomal sorting | Studied in cargo sorting |
| RNF8 | E3 ligase for monoubiquitination in DNA damage response | Investigated in chromatin remodeling |
| RNF168 | E3 ligase for monoubiquitination at DNA damage sites | Studied in genome stability |
How Is protein monoubiquitination Regulated?
Protein monoubiquitination is regulated at multiple levels. E3 ubiquitin ligases determine substrate specificity and are themselves controlled by phosphorylation, localization, and interacting proteins. For example, RPA dynamically regulates monoubiquitination of PCNA by modulating RAD18 activity. Deubiquitinating enzymes such as USP1 and OTUB1 reverse the modification, providing a dynamic equilibrium. Additionally, monoubiquitination can be primed by prior modifications and can lead to chain elongation, adding another layer of regulation. Cellular stresses such as DNA damage and ribosomal imbalance activate specific monoubiquitination pathways.
protein monoubiquitination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FANCD2 | Fanconi anemia, cancer predisposition | Knockout and point mutation cell lines for DNA repair assays |
| PCNA | Genome instability, cancer | Knock-in of ubiquitin-deficient PCNA mutants |
| RNF10 | Ribosomopathy, ribosome quality control defects | Knockout and overexpression models for ribosome profiling |
| USP1 | Cancer, DNA damage response | Knockout and inhibitor-treated models |
| UBQLN1 | Neurodegeneration, protein aggregation | Overexpression and knockout neuronal models |
Fanconi Anemia and DNA Repair Defects
Mutations in the Fanconi anemia pathway, including impaired monoubiquitination of FANCD2 and FANCI, cause Fanconi anemia, a genetic disorder characterized by bone marrow failure, developmental abnormalities, and cancer predisposition. Loss of FANCD2 monoubiquitination is a diagnostic feature and a target for therapeutic intervention.
Cancer and Genome Instability
Dysregulation of monoubiquitination contributes to cancer through defects in DNA repair, replication stress, and altered signaling. For example, impaired PCNA monoubiquitination can lead to genome instability, while overexpression of E3 ligases or deubiquitinating enzymes promotes tumorigenesis. Targeting monoubiquitination enzymes is an emerging anticancer strategy.
Ribosomopathies and Ribosome Quality Control
Monoubiquitination by RNF10 is critical for dissociating stalled ribosomes and responding to ribosomal subunit imbalance. Defects in this process are linked to ribosomopathies, a group of disorders caused by impaired ribosome biogenesis and function.
Neurodegeneration and Protein Aggregation
Monoubiquitination influences protein trafficking and degradation, and its dysregulation has been implicated in neurodegenerative diseases where ubiquitin-binding proteins such as UBQLN1 play roles in clearing aggregated proteins. Understanding monoubiquitination in neurons may reveal new therapeutic targets.
From protein monoubiquitination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of E3 ligase affect substrate monoubiquitination? | Knockout cell line (e.g., RAD18 KO) |
| Does a specific lysine mutation abolish monoubiquitination? | Point mutation knock-in (e.g., PCNA K164R) |
| Can a tagged ubiquitin substrate be tracked in live cells? | Tagged knock-in (e.g., GFP-FANCD2) |
| Does overexpression of a deubiquitinase reduce monoubiquitination? | Overexpression cell line (e.g., USP1 OE) |
| What are the downstream effectors of monoubiquitination? | Proteomics and interactomics |
| Does monoubiquitination prime chain elongation? | In vitro ubiquitination assays with mutant ubiquitin |
How to Study the protein monoubiquitination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro ubiquitination assay | Monoubiquitination of substrate | Enzyme kinetics and specificity |
| Mass spectrometry | Ubiquitination sites and stoichiometry | Proteome-wide mapping |
| Immunoblotting | Monoubiquitinated protein levels | Validation of knockout/overexpression |
| Fluorescence microscopy | Subcellular localization of monoubiquitinated proteins | DNA damage foci and endocytosis |
| Ribo-seq | Translation efficiency | Ribosome quality control |
| RNA-seq | Transcriptional changes | Pathway analysis upon gene knockout |
| Co-immunoprecipitation | Protein-protein interactions | Effector recruitment |
| CRISPR screening | Genes required for monoubiquitination | Functional genomics |
Ubiquitination Assays
In vitro ubiquitination assays using recombinant E1, E2, E3 enzymes, and substrates are used to reconstitute monoubiquitination and measure kinetics. These assays can be combined with mutant ubiquitin that cannot form chains to specifically detect monoubiquitination.
Mass Spectrometry and Proteomics
Mass spectrometry-based proteomics identifies monoubiquitination sites and quantifies changes in ubiquitination status across conditions. Enrichment of ubiquitinated peptides using di-glycine antibodies allows site-specific mapping.
Imaging and Live-Cell Tracking
Fluorescently tagged ubiquitin or substrates enable real-time visualization of monoubiquitination dynamics at specific cellular locations, such as DNA damage sites or endosomes.
Ribosome Profiling and RNA-seq
Ribosome profiling (Ribo-seq) and RNA-seq measure translation efficiency and gene expression changes upon modulation of monoubiquitination, particularly in ribosome quality control studies.
How CRISPR Can Be Used to Study GO:0006513 protein monoubiquitination
Knockout
CRISPR knockout of E3 ligases (e.g., RAD18, RNF10) or deubiquitinases (e.g., USP1) abolishes or stabilizes monoubiquitination, allowing functional studies of downstream effects.
Point Mutation
Point mutation knock-in of ubiquitin acceptor lysines (e.g., PCNA K164R) prevents monoubiquitination while preserving other functions, enabling precise dissection of the modification's role.
Knock-in
Tagged knock-in of substrates (e.g., GFP-FANCD2) allows real-time tracking and biochemical isolation of monoubiquitinated proteins.
Overexpression
Overexpression of E3 ligases or deubiquitinases modulates monoubiquitination levels, useful for gain-of-function studies and drug screening.
How EDITGENE Supports protein monoubiquitination Research
Researchers studying protein monoubiquitination-related genes often need to determine whether a candidate gene is causally involved in the modification, how specific mutations affect substrate recognition, and what downstream pathways are altered. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for protein monoubiquitination research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| TRIM25 Knockout HEK293 Cell Line | EDJ-KQ604 | Human | 7706 | Details Get a Quote |
| MGRN1 Knockout HEK293 Cell Line | EDJ-KQ909 | Human | 23295 | Details Get a Quote |
| TRIM21 Knockout HEK293 Cell Line | EDC07925 | Human | 6737 | Details Get a Quote |
| RNF152 Knockout HEK293 Cell Line | EDJ-KQ1167 | Human | 220441 | Details Get a Quote |
| ITCH Knockout HEK293 Cell Line | EDJ-KQ1468 | Human | 83737 | Details Get a Quote |
| TRIM56 Knockout HEK293 Cell Line | EDJ-KQ2107 | Human | 81844 | Details Get a Quote |
| KBTBD8 Knockout HEK293 Cell Line | EDJ-KQ2243 | Human | 84541 | Details Get a Quote |
| NEDD4L Knockout HEK293 Cell Line | EDJ-KQ3107 | Human | 23327 | Details Get a Quote |
| TRIM37 Knockout HEK293 Cell Line | EDJ-KQ3188 | Human | 4591 | Details Get a Quote |
| PRKN Knockout HEK293 Cell Line | EDJ-KQ3360 | Human | 5071 | Details Get a Quote |
| RNF10 Knockout HEK293 Cell Line | EDJ-KQ3370 | Human | 9921 | Details Get a Quote |
| UBE2T Knockout HEK293 Cell Line | EDJ-KQ3419 | Human | 29089 | Details Get a Quote |
| CBL Knockout HEK293 Cell Line | EDJ-KQ4198 | Human | 867 | Details Get a Quote |
| PEX2 Knockout HEK293 Cell Line | EDJ-KQ5615 | Human | 5828 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »
Frequently Asked Questions About protein monoubiquitination
What is protein monoubiquitination?
Protein monoubiquitination (GO:0006513) is the addition of a single ubiquitin group to a protein, a post-translational modification that often acts as a non-degradative signal.
What genes are involved in protein monoubiquitination?
Key genes include RAD18, PCNA, FANCD2, FANCI, RNF10, USP1, and OTUB1, among others.
How is monoubiquitination different from polyubiquitination?
Monoubiquitination attaches one ubiquitin, while polyubiquitination forms chains; they generate distinct structural and functional outcomes.
What is the role of PCNA monoubiquitination?
PCNA monoubiquitination recruits translesion synthesis polymerases during DNA damage, enabling replication past lesions.
Which diseases are linked to monoubiquitination defects?
Fanconi anemia, cancer, ribosomopathies, and neurodegeneration have been linked to dysregulated monoubiquitination.
How can I study monoubiquitination in the lab?
Common methods include in vitro ubiquitination assays, mass spectrometry, immunoblotting, and CRISPR knockout models.
What is the role of RNF10 in monoubiquitination?
RNF10 is an E3 ligase that promotes dissociation of stalled ribosomes and responds to ribosomal subunit imbalance.
Can monoubiquitination lead to protein degradation?
Monoubiquitination can prime ubiquitin chain elongation, which may subsequently target proteins for degradation.
What are the best CRISPR models for monoubiquitination research?
Knockout of E3 ligases, point mutation of acceptor lysines, and tagged knock-in of substrates are widely used.
How does EDITGENE support monoubiquitination research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to monoubiquitination pathways.
Conclusion
Protein monoubiquitination (GO:0006513) is a versatile and dynamic post-translational modification that controls diverse cellular processes through non-degradative signaling and priming of ubiquitin chain elongation. Its dysregulation is implicated in cancer, Fanconi anemia, ribosomopathies, and neurodegeneration, making it a compelling target for basic and translational research. Advances in CRISPR-based models and proteomic technologies continue to illuminate the enzymes, substrates, and effectors of monoubiquitination, offering new opportunities for therapeutic intervention.
References
- 1. Magits W et al.. 2022. The regulation of the protein interaction network by monoubiquitination.. Curr Opin Struct Biol 73:102333 PMID: 35176591
- 2. Sadowski M et al.. 2012. Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes.. IUBMB Life 64(2):136-42 PMID: 22131221
- 3. Hedglin M et al.. 2019. Replication protein A dynamically regulates monoubiquitination of proliferating cell nuclear antigen.. J Biol Chem 294(13):5157-5168 PMID: 30700555
- 4. Sigismund S et al.. 2004. Signaling through monoubiquitination.. Curr Top Microbiol Immunol 286:149-85 PMID: 15645713
- 5. Lehmann JA et al.. 2024. E3 ubiquitin ligase RNF10 promotes dissociation of stalled ribosomes and responds to ribosomal subunit imbalance.. Nat Commun 15(1):10350 PMID: 39609413
- 6. Carrillo Roas S et al.. 2025. Convergence of orphan quality control pathways at a ubiquitin chain-elongating ligase.. Mol Cell 85(4):815-828.e10 PMID: 39879985
- 7. Li L et al.. 2020. Structural insight into FANCI-FANCD2 monoubiquitination.. Essays Biochem 64(5):807-817 PMID: 32725171
- 8. Wu K et al.. 2024. Monoubiquitination empowers ubiquitin chain elongation.. J Biol Chem 300(3):105753 PMID: 38354782
